0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Spine Surgery Biologics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28Y13662
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Spine Surgery Biologics Market Research Report 2023
BUY CHAPTERS

Global Spine Surgery Biologics Market Research Report 2025

Code: QYRE-Auto-28Y13662
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Spine Surgery Biologics Market Size

The global market for Spine Surgery Biologics was valued at US$ 2349 million in the year 2024 and is projected to reach a revised size of US$ 3290 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Spine Surgery Biologics Market

Spine Surgery Biologics Market

Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Spine Surgery Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Surgery Biologics.
The Spine Surgery Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spine Surgery Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spine Surgery Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Spine Surgery Biologics Market Report

Report Metric Details
Report Name Spine Surgery Biologics Market
Accounted market size in year US$ 2349 million
Forecasted market size in 2031 US$ 3290 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Spine Surgery Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Spine Surgery Biologics Market growing?

Ans: The Spine Surgery Biologics Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Spine Surgery Biologics Market size in 2031?

Ans: The Spine Surgery Biologics Market size in 2031 will be US$ 3290 million.

Who are the main players in the Spine Surgery Biologics Market report?

Ans: The main players in the Spine Surgery Biologics Market are Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine, K2M, Exactech, Wright Medical Technology, X-Spine, Nutech, Arthrex

What are the Application segmentation covered in the Spine Surgery Biologics Market report?

Ans: The Applications covered in the Spine Surgery Biologics Market report are Open Surgery, Minimally Invasive Surgery

What are the Type segmentation covered in the Spine Surgery Biologics Market report?

Ans: The Types covered in the Spine Surgery Biologics Market report are Bone Graft, Bone Graft Substitute, Platelet Rich Plasma (PRP), Other

Recommended Reports

Spinal Surgery Devices

Spinal Fusion Biologics

Spinal Conditions & Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spine Surgery Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Spine Surgery Biologics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Open Surgery
1.3.3 Minimally Invasive Surgery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spine Surgery Biologics Market Perspective (2020-2031)
2.2 Global Spine Surgery Biologics Growth Trends by Region
2.2.1 Global Spine Surgery Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Spine Surgery Biologics Historic Market Size by Region (2020-2025)
2.2.3 Spine Surgery Biologics Forecasted Market Size by Region (2026-2031)
2.3 Spine Surgery Biologics Market Dynamics
2.3.1 Spine Surgery Biologics Industry Trends
2.3.2 Spine Surgery Biologics Market Drivers
2.3.3 Spine Surgery Biologics Market Challenges
2.3.4 Spine Surgery Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spine Surgery Biologics Players by Revenue
3.1.1 Global Top Spine Surgery Biologics Players by Revenue (2020-2025)
3.1.2 Global Spine Surgery Biologics Revenue Market Share by Players (2020-2025)
3.2 Global Spine Surgery Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spine Surgery Biologics Revenue
3.4 Global Spine Surgery Biologics Market Concentration Ratio
3.4.1 Global Spine Surgery Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spine Surgery Biologics Revenue in 2024
3.5 Global Key Players of Spine Surgery Biologics Head office and Area Served
3.6 Global Key Players of Spine Surgery Biologics, Product and Application
3.7 Global Key Players of Spine Surgery Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spine Surgery Biologics Breakdown Data by Type
4.1 Global Spine Surgery Biologics Historic Market Size by Type (2020-2025)
4.2 Global Spine Surgery Biologics Forecasted Market Size by Type (2026-2031)
5 Spine Surgery Biologics Breakdown Data by Application
5.1 Global Spine Surgery Biologics Historic Market Size by Application (2020-2025)
5.2 Global Spine Surgery Biologics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Spine Surgery Biologics Market Size (2020-2031)
6.2 North America Spine Surgery Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Spine Surgery Biologics Market Size by Country (2020-2025)
6.4 North America Spine Surgery Biologics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spine Surgery Biologics Market Size (2020-2031)
7.2 Europe Spine Surgery Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Spine Surgery Biologics Market Size by Country (2020-2025)
7.4 Europe Spine Surgery Biologics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spine Surgery Biologics Market Size (2020-2031)
8.2 Asia-Pacific Spine Surgery Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Spine Surgery Biologics Market Size by Region (2020-2025)
8.4 Asia-Pacific Spine Surgery Biologics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spine Surgery Biologics Market Size (2020-2031)
9.2 Latin America Spine Surgery Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Spine Surgery Biologics Market Size by Country (2020-2025)
9.4 Latin America Spine Surgery Biologics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spine Surgery Biologics Market Size (2020-2031)
10.2 Middle East & Africa Spine Surgery Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Spine Surgery Biologics Market Size by Country (2020-2025)
10.4 Middle East & Africa Spine Surgery Biologics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Spine Surgery Biologics Introduction
11.1.4 Medtronic Revenue in Spine Surgery Biologics Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 J & J
11.2.1 J & J Company Details
11.2.2 J & J Business Overview
11.2.3 J & J Spine Surgery Biologics Introduction
11.2.4 J & J Revenue in Spine Surgery Biologics Business (2020-2025)
11.2.5 J & J Recent Development
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Details
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Spine Surgery Biologics Introduction
11.3.4 Stryker Corporation Revenue in Spine Surgery Biologics Business (2020-2025)
11.3.5 Stryker Corporation Recent Development
11.4 Nuvasive
11.4.1 Nuvasive Company Details
11.4.2 Nuvasive Business Overview
11.4.3 Nuvasive Spine Surgery Biologics Introduction
11.4.4 Nuvasive Revenue in Spine Surgery Biologics Business (2020-2025)
11.4.5 Nuvasive Recent Development
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Details
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Spine Surgery Biologics Introduction
11.5.4 Zimmer Biomet Revenue in Spine Surgery Biologics Business (2020-2025)
11.5.5 Zimmer Biomet Recent Development
11.6 Orthofix International
11.6.1 Orthofix International Company Details
11.6.2 Orthofix International Business Overview
11.6.3 Orthofix International Spine Surgery Biologics Introduction
11.6.4 Orthofix International Revenue in Spine Surgery Biologics Business (2020-2025)
11.6.5 Orthofix International Recent Development
11.7 Globus Medical
11.7.1 Globus Medical Company Details
11.7.2 Globus Medical Business Overview
11.7.3 Globus Medical Spine Surgery Biologics Introduction
11.7.4 Globus Medical Revenue in Spine Surgery Biologics Business (2020-2025)
11.7.5 Globus Medical Recent Development
11.8 alphatec spine
11.8.1 alphatec spine Company Details
11.8.2 alphatec spine Business Overview
11.8.3 alphatec spine Spine Surgery Biologics Introduction
11.8.4 alphatec spine Revenue in Spine Surgery Biologics Business (2020-2025)
11.8.5 alphatec spine Recent Development
11.9 K2M
11.9.1 K2M Company Details
11.9.2 K2M Business Overview
11.9.3 K2M Spine Surgery Biologics Introduction
11.9.4 K2M Revenue in Spine Surgery Biologics Business (2020-2025)
11.9.5 K2M Recent Development
11.10 Exactech
11.10.1 Exactech Company Details
11.10.2 Exactech Business Overview
11.10.3 Exactech Spine Surgery Biologics Introduction
11.10.4 Exactech Revenue in Spine Surgery Biologics Business (2020-2025)
11.10.5 Exactech Recent Development
11.11 Wright Medical Technology
11.11.1 Wright Medical Technology Company Details
11.11.2 Wright Medical Technology Business Overview
11.11.3 Wright Medical Technology Spine Surgery Biologics Introduction
11.11.4 Wright Medical Technology Revenue in Spine Surgery Biologics Business (2020-2025)
11.11.5 Wright Medical Technology Recent Development
11.12 X-Spine
11.12.1 X-Spine Company Details
11.12.2 X-Spine Business Overview
11.12.3 X-Spine Spine Surgery Biologics Introduction
11.12.4 X-Spine Revenue in Spine Surgery Biologics Business (2020-2025)
11.12.5 X-Spine Recent Development
11.13 Nutech
11.13.1 Nutech Company Details
11.13.2 Nutech Business Overview
11.13.3 Nutech Spine Surgery Biologics Introduction
11.13.4 Nutech Revenue in Spine Surgery Biologics Business (2020-2025)
11.13.5 Nutech Recent Development
11.14 Arthrex
11.14.1 Arthrex Company Details
11.14.2 Arthrex Business Overview
11.14.3 Arthrex Spine Surgery Biologics Introduction
11.14.4 Arthrex Revenue in Spine Surgery Biologics Business (2020-2025)
11.14.5 Arthrex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Spine Surgery Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bone Graft
 Table 3. Key Players of Bone Graft Substitute
 Table 4. Key Players of Platelet Rich Plasma (PRP)
 Table 5. Key Players of Other
 Table 6. Global Spine Surgery Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Spine Surgery Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Spine Surgery Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Spine Surgery Biologics Market Share by Region (2020-2025)
 Table 10. Global Spine Surgery Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Spine Surgery Biologics Market Share by Region (2026-2031)
 Table 12. Spine Surgery Biologics Market Trends
 Table 13. Spine Surgery Biologics Market Drivers
 Table 14. Spine Surgery Biologics Market Challenges
 Table 15. Spine Surgery Biologics Market Restraints
 Table 16. Global Spine Surgery Biologics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Spine Surgery Biologics Market Share by Players (2020-2025)
 Table 18. Global Top Spine Surgery Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Surgery Biologics as of 2024)
 Table 19. Ranking of Global Top Spine Surgery Biologics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Spine Surgery Biologics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Spine Surgery Biologics, Headquarters and Area Served
 Table 22. Global Key Players of Spine Surgery Biologics, Product and Application
 Table 23. Global Key Players of Spine Surgery Biologics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Spine Surgery Biologics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Spine Surgery Biologics Revenue Market Share by Type (2020-2025)
 Table 27. Global Spine Surgery Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Spine Surgery Biologics Revenue Market Share by Type (2026-2031)
 Table 29. Global Spine Surgery Biologics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Spine Surgery Biologics Revenue Market Share by Application (2020-2025)
 Table 31. Global Spine Surgery Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Spine Surgery Biologics Revenue Market Share by Application (2026-2031)
 Table 33. North America Spine Surgery Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Spine Surgery Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Spine Surgery Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Spine Surgery Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Spine Surgery Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Spine Surgery Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Spine Surgery Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Spine Surgery Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Spine Surgery Biologics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Spine Surgery Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Spine Surgery Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Spine Surgery Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Spine Surgery Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Spine Surgery Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Spine Surgery Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Medtronic Company Details
 Table 49. Medtronic Business Overview
 Table 50. Medtronic Spine Surgery Biologics Product
 Table 51. Medtronic Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 52. Medtronic Recent Development
 Table 53. J & J Company Details
 Table 54. J & J Business Overview
 Table 55. J & J Spine Surgery Biologics Product
 Table 56. J & J Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 57. J & J Recent Development
 Table 58. Stryker Corporation Company Details
 Table 59. Stryker Corporation Business Overview
 Table 60. Stryker Corporation Spine Surgery Biologics Product
 Table 61. Stryker Corporation Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 62. Stryker Corporation Recent Development
 Table 63. Nuvasive Company Details
 Table 64. Nuvasive Business Overview
 Table 65. Nuvasive Spine Surgery Biologics Product
 Table 66. Nuvasive Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 67. Nuvasive Recent Development
 Table 68. Zimmer Biomet Company Details
 Table 69. Zimmer Biomet Business Overview
 Table 70. Zimmer Biomet Spine Surgery Biologics Product
 Table 71. Zimmer Biomet Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 72. Zimmer Biomet Recent Development
 Table 73. Orthofix International Company Details
 Table 74. Orthofix International Business Overview
 Table 75. Orthofix International Spine Surgery Biologics Product
 Table 76. Orthofix International Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 77. Orthofix International Recent Development
 Table 78. Globus Medical Company Details
 Table 79. Globus Medical Business Overview
 Table 80. Globus Medical Spine Surgery Biologics Product
 Table 81. Globus Medical Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 82. Globus Medical Recent Development
 Table 83. alphatec spine Company Details
 Table 84. alphatec spine Business Overview
 Table 85. alphatec spine Spine Surgery Biologics Product
 Table 86. alphatec spine Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 87. alphatec spine Recent Development
 Table 88. K2M Company Details
 Table 89. K2M Business Overview
 Table 90. K2M Spine Surgery Biologics Product
 Table 91. K2M Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 92. K2M Recent Development
 Table 93. Exactech Company Details
 Table 94. Exactech Business Overview
 Table 95. Exactech Spine Surgery Biologics Product
 Table 96. Exactech Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 97. Exactech Recent Development
 Table 98. Wright Medical Technology Company Details
 Table 99. Wright Medical Technology Business Overview
 Table 100. Wright Medical Technology Spine Surgery Biologics Product
 Table 101. Wright Medical Technology Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 102. Wright Medical Technology Recent Development
 Table 103. X-Spine Company Details
 Table 104. X-Spine Business Overview
 Table 105. X-Spine Spine Surgery Biologics Product
 Table 106. X-Spine Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 107. X-Spine Recent Development
 Table 108. Nutech Company Details
 Table 109. Nutech Business Overview
 Table 110. Nutech Spine Surgery Biologics Product
 Table 111. Nutech Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 112. Nutech Recent Development
 Table 113. Arthrex Company Details
 Table 114. Arthrex Business Overview
 Table 115. Arthrex Spine Surgery Biologics Product
 Table 116. Arthrex Revenue in Spine Surgery Biologics Business (2020-2025) & (US$ Million)
 Table 117. Arthrex Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Spine Surgery Biologics Picture
 Figure 2. Global Spine Surgery Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Spine Surgery Biologics Market Share by Type: 2024 VS 2031
 Figure 4. Bone Graft Features
 Figure 5. Bone Graft Substitute Features
 Figure 6. Platelet Rich Plasma (PRP) Features
 Figure 7. Other Features
 Figure 8. Global Spine Surgery Biologics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Spine Surgery Biologics Market Share by Application: 2024 VS 2031
 Figure 10. Open Surgery Case Studies
 Figure 11. Minimally Invasive Surgery Case Studies
 Figure 12. Spine Surgery Biologics Report Years Considered
 Figure 13. Global Spine Surgery Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Spine Surgery Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Spine Surgery Biologics Market Share by Region: 2024 VS 2031
 Figure 16. Global Spine Surgery Biologics Market Share by Players in 2024
 Figure 17. Global Top Spine Surgery Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Surgery Biologics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Spine Surgery Biologics Revenue in 2024
 Figure 19. North America Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Spine Surgery Biologics Market Share by Country (2020-2031)
 Figure 21. United States Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Spine Surgery Biologics Market Share by Country (2020-2031)
 Figure 25. Germany Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Spine Surgery Biologics Market Share by Region (2020-2031)
 Figure 33. China Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Spine Surgery Biologics Market Share by Country (2020-2031)
 Figure 41. Mexico Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Spine Surgery Biologics Market Share by Country (2020-2031)
 Figure 45. Turkey Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Spine Surgery Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Medtronic Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 49. J & J Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 50. Stryker Corporation Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 51. Nuvasive Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 52. Zimmer Biomet Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 53. Orthofix International Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 54. Globus Medical Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 55. alphatec spine Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 56. K2M Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 57. Exactech Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 58. Wright Medical Technology Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 59. X-Spine Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 60. Nutech Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 61. Arthrex Revenue Growth Rate in Spine Surgery Biologics Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS